27th Jun 2019 13:38
RNS Number : 6908D
Immupharma PLC
27 June 2019
27 JUNE 2019
ImmuPharma PLC
("ImmuPharma" or the "Company")
2019 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
-Ends-
For further information please contact: ImmuPharma PLC (www.immupharma.com) Tim McCarthy, Chairman | + 44 (0) 207 152 4080 | Dimitri Dimitriou, Chief Executive Officer | | Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 | SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson | +44 (0) 203 368 8974 +44 (0) 203 815 8880 +44 (0) 1483 413500 | | | | | | | | | | | |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
AGMUBOURKVANUAR
Related Shares:
Immupharma
